Reproductive issues in women on direct oral anticoagulants

by Jan Beyer‐Westendorf, Sandra Marten
Published 2021-05-01

The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation

by Jan Beyer-Westendorf, Matthew Fay, Walid Amara
Published 2021-07-01

Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry

by Jan Beyer-Westendorf, Sandra Marten, Luise Tittl, Christiane Naue, Martin Bornhäuser
Published 2021-04-01

Library of UV-Visible Absorption Spectra of Rare Earth Orthophosphates, <i>Ln</i>PO₄ (<i>Ln</i> = La-Lu, except Pm)

by Suchinder K. Sharma, Thomas Behm, Thomas Köhler, Jan Beyer, Richard Gloaguen, Johannes Heitmann
Published 2020-07-01

Edoxaban dosing patterns in real life practice – Results from the DRESDEN NOAC REGISTRY

by Jan Beyer-Westendorf, Sandra Marten, Christiane Naue, Christina Köhler, Luise Tittl, Martin Bornhäuser
Published 2021-12-01

The Potential of Reflectance and Laser Induced Luminescence Spectroscopy for Near-Field Rare Earth Element Detection in Mineral Exploration

by Sandra Lorenz, Jan Beyer, Margret Fuchs, Peter Seidel, David Turner, Johannes Heitmann, Richard Gloaguen
Published 2018-12-01

Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination – A Case Report

by Martin Koch, Sybille Fuld, Jan M. Middeke, Julia Fantana, Simone von Bonin, Jan Beyer-Westendorf
Published 2021-07-01

Fast 2D Laser-Induced Fluorescence Spectroscopy Mapping of Rare Earth Elements in Rock Samples

by Peter Seidel, Sandra Lorenz, Thomas Heinig, Robert Zimmermann, René Booysen, Jan Beyer, Johannes Heitmann, Richard Gloaguen
Published 2019-05-01

New charge-transfer states in blends of ZnPC with F8ZnPC

by Lukas Graf, Katrin Ortstein, Louis P. Doctor, Marco Naumann, Jan Beyer, Johannes Heitmann, Karl Leo, Martin Knupfer
Published 2021-02-01

Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in at-risk patient groups: pregnancy, elderly and obese patients

by Benjamin Brenner, Roopen Arya, Jan Beyer-Westendorf, James Douketis, Russell Hull, Ismail Elalamy, Davide Imberti, Zhenguo Zhai
Published 2019-12-01

Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill

by Benjamin Brenner, Russell Hull, Roopen Arya, Jan Beyer-Westendorf, James Douketis, Ismail Elalamy, Davide Imberti, Zhenguo Zhai
Published 2019-04-01

COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study

by Alexander T. Cohen, Anthony Maraveyas, Jan Beyer-Westendorf, Agnes Y. Y. Lee, Lorenzo G. Mantovani, Miriam Bach, on behalf of the COSIMO Investigators
Published 2018-09-01

Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs – A Systematic Review and Meta-analysis

by Andrea Martini, Job Harenberg, Rupert Bauersachs, Jan Beyer-Westendorf, Mark Crowther, Jonathan Douxfils, Ismail Elalamy, Christel Weiss, Svetlana Hetjens
Published 2021-07-01

Homoarginine and methylarginines independently predict long-term outcome in patients presenting with suspicion of venous thromboembolism

by Roman N. Rodionov, Jan Beyer-Westendorf, Stefanie M. Bode-Böger, Lisa Eggebrecht, Stavros Konstantinides, Jens Martens-Lobenhoffer, Markus Nagler, Jürgen Prochaska, Philipp Wild
Published 2021-05-01

Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin

by Kochawan Boonyawat, Anthonie W. A. Lensing, Martin H. Prins, Jan Beyer‐Westendorf, Paolo Prandoni, Ida Martinelli, Saskia Middeldorp, Akos F. Pap, Jeffrey I. Weitz, Mark Crowther
Published 2021-02-01

International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

by Jan Beyer-Westendorf, A. John Camm, Keith A. A. Fox, Jean-Yves Le Heuzey, Sylvia Haas, Alexander G. G. Turpie, Saverio Virdone, Ajay K. Kakkar, for the RIVER Registry Investigators
Published 2019-04-01

Rivaroxaban Versus Warfarin for Management of Obese African Americans With Non-Valvular Atrial Fibrillation or Venous Thromboembolism: A Retrospective Cohort Analysis

by Olivia S. Costa PharmD, Jan Beyer-Westendorf MD, Veronica Ashton MPH, Dejan Milentijevic PhD, MBA, Kenneth Todd Moore MS, Thomas J. Bunz PharmD, PhD, Craig I. Coleman PharmD
Published 2020-10-01

Novel biomarkers to detect occult cancer in patients with unprovoked venous thromboembolism: Rationale and design of the PLATO-VTE study

by Noémie Kraaijpoel, Frits I. Mulder, Marc Carrier, Annabel van Lieshout, Tom Würdinger, Myron G. Best, Bart J.M. van Vlijmen, Yassene Mohammed, Luis Jara-Palomares, Pieter W. Kamphuisen, Marcello Di Nisio, Walter Ageno, Jan Beyer-Westendorf, Thomas Vanassche, Frederikus A. Klokm, Hans-Martin Otten, Mike J.L. Peters, Benilde Cosmi, Marije ten Wolde, Patrick M.M. Bossuyt, Harry R. Büller, Nick van Es
Published 2021-01-01

Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin

by Roisin Bavalia, Ingrid M. Bistervels, Wim G. Boersma, Isabelle Quere, Dominique Brisot, Nicolas Falvo, Dominique Stephan, Francis Couturaud, Sebastian Schellong, Jan Beyer‐Westendorf, Karine Montaclair, Waleed Ghanima, Marije ten Wolde, Michiel Coppens, Emile Ferrari, Olivier Sanchez, Patrick Carroll, Pierre‐Marie Roy, Susan R. Kahn, Karina Meijer, Simone Birocchi, Michael J. Kovacs, Amanda Hugman, Hugo ten Cate, Hilde Wik, Gilles Pernod, Marie‐Antoinette Sevestre‐Pietri, Michael A. Grosso, Minggao Shi, Yong Lin, Barbara A. Hutten, Peter Verhamme, Saskia Middeldorp, the Hokusai post‐PE study investigators
Published 2021-07-01